Pedro Perez/LinkedIn
Apr 3, 2026, 17:12
Pedro Perez: Timing Is the Biggest Challenge in Treating DVT
Pedro Perez, Senior Vascular Consultant at Argon Medical Devices, Inc., shared a post on LinkedIn:
“What I’ve learned after years working alongside physicians treating VTE:
The biggest challenge in treating Deep Vein Thrombosis isn’t technology.
It’s timing.
Too often patients arrive after symptoms have been present for days — sometimes weeks — when clot burden has already begun to organize.
When VTE programs work well inside hospitals, three things are usually happening:
- Early identification in the ER or inpatient setting
- Clear referral pathways to interventional specialists
- Collaboration between specialties (IR, vascular surgery, cardiology)
Technology continues to evolve, but systems of care are what ultimately determine outcomes.
The hospitals seeing the best results are those building true VTE programs, not just treating individual cases.”
Stay updated with Hemostasis Today.
-
Nov 17, 2026, 23:45Cajetan Reichardt: LAAO vs. OAC in AF – Balancing Nonprocedural Bleeding and Ischemic Stroke Risk
-
Nov 17, 2026, 23:42Brian Tegtmeyer: Expanding Pre-Hospital Administration of Low-Titer O Positive Whole Blood
-
Nov 17, 2026, 23:41Mansi Kala: Advancing Hematology – From Evidence to Clinical Excellence
-
Nov 17, 2026, 23:40Nathan Connell: Registered for the WFH Comprehensive Care Summit 2027 in Prague
-
Nov 17, 2026, 23:38Yaariv Khaykin: Does Reducing AF Burden After Ablation Change the Need for Anticoagulation?
-
Nov 17, 2026, 23:38Amos Gitonga Mbaabu: Strengthening Care and Advocacy for Haemophilia and SCD across Southern Africa
-
Nov 17, 2026, 23:35Muhammad Sameed Altaf: A Decade of Working Together for Thalassemia Awareness and Patient Support
-
Nov 17, 2026, 23:34Ahmed Bennis: Is Aspirin Therapy Enough for VTE Prevention After Arthroplasty?
-
Nov 17, 2026, 23:33Remi Remakanth: The Role of Transfusion Medicine in HLA Antibody Testing and Transplant Desensitization